An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver diseaseTimothy J. Kendall(MRC Centre for Regenerative Medicine), Jonathan Fallowfield(MRC Centre for Regenerative Medicine)Nature MedicineOctober 30, 202310.1038/s41591-023-02602-2Cited by 69SaveCiteExport RISWatch citationsRelated PapersSerelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial|PLoS Medicine|2017|64